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Abstract
Angiogenesis, the growth of capillaries from pre-existing ones, plays a key role in cancer progression. Tumours release tumour
angiogenic factors into the extracellular matrix that trigger angiogenesis once they reach the vasculature. The neovasculature
provides nutrients and oxygen to the tumour. In the extracellular matrix, the interstitial fluid moves driven by pressure
differences and may affect the distribution of tumour angiogenic factors, and, in turn, tumour vascularisation. In this work,
we propose a hybrid mathematical model to investigate the influence of fluid flow in tumour angiogenesis. Our model shows
the impact of interstitial flow in a time-evolving capillary network using a continuous approach. The flow model is coupled
to a model of angiogenesis that includes tip endothelial cells, filopodia, capillaries and tumour angiogenic factor. The tumour
angiogenic factor transport equation considers diffusive mechanisms, but also the convective transport produced by interstitial
flow. Our simulations predict a significant alteration of the new vascular networks, which tend to grow more prominently against
the flow. The model suggests that interstitial flow may produce increased tumour malignancies and hindered treatments.
Subject areas: Computational biology.
Keywords: Angiogenesis, interstitial flow, mathematical modelling, phase field.
1 Introduction
At the early stages of tumour development, cancerous cells
rely on the pre-existing vasculature for their nourishment [1].
However, their accelerated cellular multiplication eventually
renders this supply insufficient and creates regional hypoxia5
(oxygen- and nutrient-deprived regions) [1]. Under these con-
ditions some mutated tumour cells are able to release sig-
nalling factors, commonly known as tumour angiogenic fac-
tors (TAFs). When these factors bind to the endothelial cells
that form the pre-existing vasculature they initiate angio-10
genesis, that is, the growth of new capillaries [2–4]. Tumour
angiogenic factors promote a phenotype change in endothe-
lial cells: Some cells known as tip endothelial cells (TECs)
become migratory, while others known as stalk endothelial
cells become proliferative. The mechanism that selects the15
phenotypical change is called lateral inhibition [5]. TECs di-
rect their migration towards the tumour following gradients
of tumour angiogenic factor aided by cytoplasmatic projec-
tions or filopodia [6, 7]. Stalk cells trail behind them forming
a new capillary by proliferation. The process continues until20
the stimuli end or the new capillary fuses with another one
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(anastomosis). As a result, the tumour becomes vascularised,
hypoxic regions become normoxic and the lesion continues
its growth.
Tumour angiogenesis research has been driven by the 25
discovery of the biochemical signalling pathways that reg-
ulate the process. The role of biophysical cues, however, is
receiving increasing attention. Significant progress has been
made in understanding how pressure and shear stresses pro-
duced by intravascular flow control angiogenesis by remod- 30
elling vessel networks [8–15]. The role of interstitial flow in
tumour angiogenesis has received little attention. However,
since tumour angiogenesis is tightly regulated by soluble sub-
stances that are transported through the extracellular ma-
trix (ECM), the influence of convective transport produced 35
by interstitial flow may be significant, especially in the tu-
mour micro-environment, where strong interstitial flows have
been reported [16, 17]; see Fig. 1. Although recent notewor-
thy advances in microfabrication and microfluidic technology
that allow the creation of in vitro multicellular microvascu- 40
lar tissues with simultaneous control of interstitial flow and
the TAF spatial concentration gradient have demonstrated
the importance of interstitial flow [18], the mechanistic un-
derstanding of the process has remained elusive. Achieving
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Figure 1. Angiogenesis starts with the activation of tip endothelial
cells by tumour angiogenic factors, which are released in hypoxic re-
gions and transported to nearby capillaries. Tumour angiogenic factor
transport is usually assumed to be purely diffusive, but convective
transport by interstitial flow may significantly influence tumour angio-
genesis.
further progress requires controlling and/or measuring si-45
multaneously TAF concentrations and interstitial flow in an
experiment that recreates conditions similar to those encoun-
tered in vivo. This is challenging because there is a tight
two-way coupling: Flow has a strong impact on angiogenesis,
at least modifying the spatial distribution of TAF; and the50
TAF distribution controls the geometry and topology of the
neovasculature, which, in turn, determines flow. Computa-
tional modelling may be beneficial to study this problem be-
cause, under certain assumptions, it provides high-resolution
information of the fluid flow and TAF distributions. Previous55
mathematical models have shown their potential as predic-
tive tools in angiogenesis (see [19–23]) but, to the best of
our knowledge, none of them has coupled angiogenesis with
a multidimensional description of the intra-, trans-, and ex-
travascular flow in a capillary network that evolves in time.60
Although our interest is the effect of extravascular (i.e., inter-
stitial) flow on angiogenesis, the fluid flow in the interstitium
is to a great extent determined by the intravascular and
transvascular flow in the growing vascular network. There-
fore, we propose a model that couples intra-, trans-, and ex-65
travascular flow with tumour angiogenesis, accounting for the
convective transport of tumour angiogenic factors. We show
that the model naturally predicts the experimental observa-
tion that new vasculature grows more prominently against
the flow. We also use the model to make predictions on the70
impact of interstitial flow on the angiogenic switch1 of small
tumours and the effect of elevated intratumoral pressure that
produces flow radially outward of a cancerous lesion.
2 Model of convection-mediated angiogen-
esis75
Our theoretical framework is based on an angiogenesis model
that is coupled to a fluid flow theory. The angiogenesis model,
based on the work developed in [24–28], is a hybrid theory
with two continuous partial differential equations and a set
of discrete agents. The continuous equations describe the80
location of the capillaries and the concentration of tumour
angiogenic factors. There are several relevant tumour an-
1The term angiogenic switch refers to the modification of the bal-
ance between pro- and anti-angiogenic factors during tumour develop-
ment favouring a pro-angiogenic result. As a consequence the tumour
evolves from a dormant avascular state to a vascular lesion, which
generally leads to malignant tumour progression [2].
giogenic factors, but the vascular endothelial growth factor
(VEGF) is considered one of the most potent ones [29]. For
simplicity, our model for tumour angiogenic factors considers 85
VEGF only. The discrete agents represent tip endothelial
cells (TECs) which lead the growth of new capillaries in an-
giogenesis. The fluid flow model is based on Darcy’s law and
its unknowns are fluid velocity, u, and pressure, p. The angio-
genesis and the fluid flow models are fully coupled: the fluid 90
transports tumour angiogenic factor, which modifies the cap-
illary field (both through endothelial cell proliferation and
through the creation of TECs), and the distribution of capil-
laries controls the fluid flow — much of the fluid transport
occurs through the capillaries, but the model accounts for 95
extravasation and interstitial flow. In the rest of the section
we describe the models separately.
The angiogenesis model
The continuous variables (c and f) The location of
capillaries (defined by c) and the VEGF concentration f 100
comprise the continuous part of the model. These equations
will be later coupled to the flow model which determines the
velocity and pressure inside and outside the capillaries. There-
fore, to avoid meshing the vessels, we resort to the phase-field
method [30–32], which permits an implicit description of the 105
capillaries through a continuous field c defined on the entire
tissue. The phase-field c is governed by the equation
∂c
∂t
= ∇ ·
(
M∇
(
µ (c)− λ2∆c
))
+ B (f) cH (c) , (1)
whereM > 0 is the mobility, and H is the Heaviside function.
The function µ (c) = −c + c3 represents the derivative of a
double-well potential that drives the solution to c = 1 or to 110
c = −1, which can be interpreted as stable uniform solutions
in the absence of tumour angiogenic factor. The regions of
the tissue where c ∼ 1 represent the capillaries, while c ∼ −1
represents the extracellular matrix. The transition between
the capillaries and the extravascular space is smooth and 115
occurs across a length scale proportional to λ; see a one-
dimensional solution to Eq. (1) in Fig. 2. The function B
represents the endothelial cell proliferation and is defined as
B(f) =
{
Bf if f < fp
Bfp if f ≥ fp
. (2)
Here,B is the proliferative rate constant and fp is the tumour
angiogenic factor condition for highest proliferation. 120
The tumour angiogenic factor is produced in hypoxic re-
gions, diffuses throughout the extracellular matrix, and is
consumed by endothelial cells [33]. In the proposed model,
additionally, the tumour angiogenic factor is convected by
the fluid [34]. The proposed governing equation is 125
∂f
∂t
= ∇· (D∇f)−∇· (uf) +P (d) (fhyc − f)−U (c) f, (3)
where D is the diffusion constant of VEGF, u is the fluid
velocity, fhyc is the maximum tumour angiogenic factor pro-
duced in a hypoxic region, and P and U are the tumour
angiogenic factor production and uptake by capillaries, re-
spectively. These functions are defined by 130
P(d) =
{
P exp(−t∗/2) if d < R
0 if d ≥ R (4)
and
U(c) =
{
Uuc if c ≥ 0
−Udc if c < 0
, (5)
where P is the production rate, d is the distance to the
closest hypoxic cell, R is an average cell radius, Uu is the
2
endothelial cell uptake rate, and Ud is the tumour angiogenic
factor natural decay rate and uptake rate by other cells. The135
value of t∗ is zero, except when there is a capillary in the
neighbourhood of a hypoxic cell. When a capillary is at a
distance short enough so as to effectively provide oxygen
to a hypoxic cell, t∗ starts counting time and the VEGF
production rate decreases as per (5). We assume that the140
VEGF production rate starts decreasing (t∗ > 0) when a
capillary is at a distance δnox or lower to the hypoxic cell,
where δnox is the oxygen diffusion length scale.
The discrete agents (TECs) and their coupling to the
continuous description Tip endothelial cells are mod-145
elled as circular discrete agents with radius R. Discrete agents
can be created at any point in the domain if the following con-
ditions are met: 1) c > cact, 2) f > fact, and 3) the distance
to the closest TEC is greater than δ4. The first condition
indicates that TECs can only be located in regions of the150
tissue occupied by endothelial cells; the second one expresses
that TEC activation requires that VEGF has reached the ex-
isting capillaries with sufficient concentration; the third one
accounts for the lateral inhibition mechanism that prevents
the formation of several sprouts in the same region. An active155
TEC initially moves with a constant velocity vtec = χ ∇f|∇f | ,
where χ is the chemotactic speed. Once a TEC is outside its
parent capillary, it develops filopodia, which we model as a
set of check points distributed in an annular sector, centred
in the direction of the tumour angiogenic factor gradient,160
with angle 2pi/3, and with internal and external radius 2R
and 4R, respectively (see Fig. 2 in [28]). A positive check in
one of these points (c > −0.9) implies that filopodia have
detected a nearby endothelial cell and the TEC alters its
velocity direction towards it. Finally, TECs get deactivated165
if they fail to meet any of the above-mentioned conditions
for activation or if they encounter another TEC or capillary
in their migration path (anastomosis).
There is a two-way coupling between the discrete agents
and the continuous variables. On the one hand, the activation,170
movement, and deactivation of the agents depends on point-
wise evaluations of the continuous variables. On the other
hand, the value of the phase-field c is overwritten at the region
occupied by each TEC (a circle with radius R). In particular,
c takes the value one within this region such that TECs form175
automatically part of the intravascular region defined in this
theory. See text T1 in the electronic supplementary material
for more details of the discrete agents.
The fluid flow model
Our goal is to understand how fluid flow controls angiogen-
esis through VEGF convection in the extravascular space.
Therefore, we are mainly interested on the interstitial flow.
However, interstitial flow emanates from capillaries and we
need some notion of intravascular flow. Developing an accu-
rate computational model that accounts for coupled intra-
and extra-vascular flow on a time-evolving capillary network
is an open research problem that is out of the scope of this
paper [35–40]. Therefore, we resort to a porous media flow
model in which capillaries are modelled as highly permeable
regions and the vascular wall as a low hydraulic conductivity
layer. The extravascular space is assigned a hydraulic con-
ductivity value taken from experiments. Thus, considering
that blood plasma and the interstitial fluid have the same
properties, and under the assumptions of incompressible, sta-
tionary, and creeping flow, the governing equations may be
written as
∇ · u = 0, (6)
u = −K∇p, (7)
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Figure 2. Hydraulic conductivity function. We plot K as a function of
c = tanh(−x/(√2λ)), that is, the 1D solution to the phase-field equa-
tion on an infinite domain. The phase-field creates smooth interfaces
that permit the differentiation of intravascular, transvascular, and ex-
travascular regions. Accordingly, the hydraulic conductivity displays
three plateaus, one per region, connected by smooth transitions. In
this plot, we take κe = 0.15, κ¯i = 10, κ¯t = 0.1, and λ = 1. Although
these values are not realistic, we use them in the plot to enable a
simple visualisation of the hydraulic conductivity as a function of c.
where K is the hydraulic conductivity function. We define K 180
by using three constant values associated to the intravascular,
the transvascular, and the extravascular regions. The value
of K transitions smoothly as we move from one of the regions
to another. As one of the main variables of the angiogenesis
model is the location of capillaries c, we could straightfor- 185
wardly delineate the extra- and intra-vascular regions. More
interestingly, recalling that the dynamics of c is governed by
a phase-field equation that generates thin but smooth tran-
sitions between these regions, we make use of this property
to define the following hydraulic conductivity function 190
K = K (c, ‖∇c‖) = κe
(
κ¯t + ϑ (c) T (‖∇c‖)
)
, (8)
where κe is the extravascular hydraulic conductivity, κ¯t =
κt/κe is the normalised transvascular hydraulic conductiv-
ity and κt is the transvascular hydraulic conductivity. Fig. 2
shows the spatial variation of K across a cut-line perpendicu-
lar to a capillary wall. The red line shows a generic solution 195
of the phase-field equation, which transitions from c ∼ 1
(intravascular region) to c ∼ −1 (extravascular space). In
equation (8), ϑ is a function of the phase field that accounts
for the different permeabilities of the intravascular and ex-
travascular regions through the expression 200
ϑ (c) = 1 + κ¯
i − 1
2 (tanh (3c) + 1)− κ¯
t, (9)
where κ¯i = κi/κe is the normalised intravascular hydraulic
conductivity and κi is the intravascular hydraulic conductiv-
ity. The last factor of equation (8), T , can be understood
as a weighting function that modifies ϑ in the transvascular
region and is defined as 205
T (‖∇c‖) = 12 −
1
2 tanh
(
10λ
(
‖∇c‖ − 1
2
√
2λ
))
. (10)
T depends on the gradient of the phase-field in such a way
that only affects K in the transvascular region, that is, where
the gradient is large. The term 1/(2
√
2λ) and the factor 10λ
are needed to ensure that if the thickness of the capillary
wall changes, the hydraulic conductivity function will adapt 210
accordingly. Although, in principle, it should be possible to
define K using the value of c only, we found that utilising also
||∇c|| permits a more accurate location of the transvascular
region. This formulation is also less sensitive to numerical
errors in the computation of c. 215
3
Parameters
Table 1 summarises the values of the parameters of the model.
There, we categorise the parameters according to the different
sub-models. Those for which there was no available data
are estimated, as explained below. The rest are taken from220
experimental measurements or have been used in previous
models of tumour angiogenesis.
The fluid flow problem is completely defined by three pa-
rameters, namely, κe, κi, and κt. As shown in the table, the ex-
travascular hydraulic conductivity is 5.008× 10−8 cm2 s−1 mmHg−1,225
which is within the range of data from the literature [15, 51].
In the intravascular region the fluid flows more easily than
through the interstitium, thus, κi  κe. For the capillary
networks considered in this paper, taking κi/κe = 103 would
produce intravascular velocities of the order of ∼ 0.1 mm s−1,230
which are consistent with the estimates in the literature for
non-tumoral capillaries [52]. However, the heterogeneous leak-
iness of tumour vessels along with other morphological ab-
normalities of the network produce a velocity that is one
to three orders of magnitude lower [52, 53]. Therefore, we235
took κi/κe = 10. Tumour-induced capillaries are charac-
terised by being leaky, but their permeability is difficult to
estimate. In addition, vascular permeability depends on the
local VEGF concentration. In this paper we take the con-
stant value κt = 5.008× 10−9 cm2 s−1 mmHg−1, which is ∼ 5240
times larger than the value reported in [54] for oxygen per-
meability through a physiological vascular wall.
The remaining parameters belong to the continuous and
discrete angiogenesis model, many of which have been al-
ready used in other mathematical models. In particular, fol-245
lowing [42], we set the diffusion coefficient of VEGF to D =
1.002× 10−7 cm2 s−1. The mobility of the phase field sets the
time scale for the capillary remodelling dynamics, which is
much slower than the diffusion of VEGF. Following [28], we
set the same ratio D/M , so thatM = 1.002× 10−11 cm2 s−1.250
The length scale λ is proportional to the width of the intravas-
cular region, that is, the capillary wall. We set its value to
1.25 µm so that we obtain an intravascular region of the order
of 1 µm [41]. The values of the proliferative constant and the
tumour angiogenic factor condition for maximum prolifera-255
tion were defined following the parametric study in [24]. The
endothelial cell uptake is Uu = D/R2 = 4.006× 10−1 s−1 so
that the tumour angiogenic factor cannot penetrate inside
a capillary farther than the radius of a tip endothelial cell
R. We take R = 5µm, which is within the range of mea-260
sured values [50]. Taking an average value for the half-life of
VEGF equal to 3 h [45], the value of the natural decay rate
results Ud = 6.410× 10−5 s−1. P is a purely computational
constant that acts as a penalty parameter. We found through
numerical simulations that the value of P has almost no in-265
fluence on the solution. Therefore, we set it to a value high
enough to drive the value of f to fhyc in the hypoxic regions
without affecting the convergence of the numerical method.
In particular, we used the value P = 6.410× 10−2 s−1. In
the absence of an equation for the nutrient diffusion as in270
[48, 49] and considering the high nutrient uptake of cancer
cells and the faulty structure of tumour-induced capillaries
we have set δnox to 25µm. Furthermore, we have set δ4 to
16R, so that TECs impede the activation of other TECs in
their neighbourhood.275
The value fhyc = 180 ng ml−1, which defines the maxi-
mum concentration of VEGF, was taken from mouse cornea
micropocket angiogenesis assays [43, 44]. By setting the chemo-
tactic speed χ to 0.194µm s−1, we obtain TEC velocity values
within the range observed in [46, 47]. Under physiological con-280
ditions, every cell is at a maximum of 100 to 200 µm from a
blood vessel. We have set the tumour angiogenic factor condi-
tion for TEC activation fact = 0.72 ng ml−1 so that hypoxic
cells located farther than 200µm away from a capillary can
activate TECs. 285
Numerical method
Our mathematical model is composed by a continuous and
a discrete part. The continuous compartment is described
by partial differential equations. The discrete part involves
algorithms for the activation, movement and deactivation 290
of TECs and filopodia probing, as well as the coupling with
the continuous variables. We developed an efficient numerical
method that robustly handles these complexities. The spatial
discretization of the continuous equations is performed using
isogeometric analysis [55] — a generalisation of the finite el- 295
ement method that permits a straightforward discretization
of equations with spatial derivatives of order higher than two,
such as, equation (1). Our variational formulation is based
on the Galerkin method. We confirmed that for the elemen-
tal Peclet numbers (see electronic supplementary material, 300
text T1) considered in this paper our formulation did not
present convective instabilities. This was done by perform-
ing a mesh refinement study and comparing our Galerkin
solutions with those obtained using the streamline upwind
Petrov-Galerkin method — a standard stabilised finite ele- 305
ment method [56]. The coupling between the continuous and
the discrete compartments was performed using the concept
of templates, which allows to blend the discrete agents into
the continuous formulation using a generalisation of an exact
solution to the phase-field equation; see [25]. Time integra- 310
tion was performed using the generalised-α method, which
is a second-order scheme that features unconditional linear
stability. The details of the algorithm may be found in the
electronic supplementary material, text T1.
Basic features of the model 315
Here, we study angiogenesis with and without VEGF convec-
tion. These simulations illustrate the features and capabilities
of the model, showing the type of information that can be
extracted from our computational approach. As shown in
Fig. 3 and video V1 in the electronic supplementary mate- 320
rial, we perform simulations on a square piece of tissue of
size 375 µm× 375µm. We place two 6.25µm-thick capillaries
along the left and right sides of the square and a hypoxic
region at its centre, mimicking a 68.75µm-radius, hypoxic
tumour. Note that the initial conditions of capillaries and 325
hypoxic region in this simulation (as well as in the remain-
ing simulations in this work) are symmetric, so that we can
isolate the effect of interstitial flow with respect to geometric
asymmetry. We arbitrarily define the left-hand side capillary
to be the arterial side of the vascular bed and the right-hand 330
side capillary to be the venous side. Following [15, 57, 58],
we assume that the pressure difference between the arterial
and the venous side in a capillary bed is ∼ 10 mmHg. There-
fore, we impose the boundary condition p = 10 mmHg and
p = 0 mmHg on the left-hand side and right-hand side capil- 335
laries, respectively. The remaining boundary conditions are
free-flux conditions. We choose this configuration, because
it allows to quantify the importance of interstitial flow in a
common setting: A small growing tumour placed far enough
from the capillaries to be hypoxic and trigger angiogenesis. 340
Fig. 3 shows two numerical simulations: One in which
VEGF convection is neglected [panels (a) to (d)] and one
with the full model [panels (e) to (p)]. For the simulation
that accounts for interstitial flow, the figure shows snapshots
of the evolution of the four unknowns of the model. Initially, 345
there is a constant pressure drop from the higher pressure
on the left-hand side capillary to the lower one in the right-
hand side capillary; see Fig. 3i. Fluid particles travel from
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Figure 3. Non-convective versus convective vascular patterns. Vascular patterns without VEGF convection (a-d) and with VEGF convection (e-p)
create different vascular networks (q). The numerical method captures the fluid velocity and the phase-field, as shown by the velocity magnitude, u,
and the phase-field profile, c, along a cut-line (r) and streamlines (s). We used a mesh composed by 512× 512 elements in these simulations.
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Table 1. Values of the parameters grouped by sub-models.
Description Value Reference
M Mobility 1.002× 10−11 cm2s [28]
λ Interface width 1.25 µm [41]
B Proliferative rate 4.987× 10−6 mlng s [24]
fp VEGF condition for highest proliferation 54 ngml [24]
D Diffusion 1.002× 10−7 cm2s [42]
fhyc Maximum VEGF production 180 ngml [43, 44]
P Production 6.410× 10−2 1s Numerical
Uu Endothelial cell uptake 4.006× 10−1 1s Estimated
Ud Natural decay 6.410× 10−5 1s [45]
χ Chemotactic speed 0.194 µms [46, 47]
δnox Nutrient and oxygen diffusion length 25µm [48, 49]
cact Condition for TEC activation 0.9 [24]
fact Condition for TEC activation 0.72 ngml [28]
δ4 Condition for TEC activation 80µm [48, 49]
R TEC radius 5 µm [50]
κe Extravascular hydraulic conductivity 5.008× 10−8 cm2smmHg [15, 51]
κ¯i Normalised intravascular hydraulic conductivity 10.0 [52, 53]
κ¯t Normalised transvascular hydraulic conductivity 0.1 [54]
left to right following straight trajectories as shown by the
streamlines (black lines) in Fig. 3m. The fluid carries VEGF350
to the right-hand side (Fig. 3e) altering the symmetric dis-
tribution obtained when only diffusive mechanisms are in
action (Fig. 3a). Early after the simulation starts, the non-
symmetric VEGF distribution promotes dissimilar TEC ac-
tivation: While the purely diffusive VEGF distribution acti-355
vates five TECs from each capillary, convection promotes the
early activation of only two TECs from the left-hand side
parent capillary; see Fig. 3f. This incipient vascular network
has already altered the pressure and velocity fields (Figs 3j
and 3n) highlighting how strongly the variables of the model360
are coupled. Later in the simulation (Figs 3c and 3g), the
newly-created capillaries have pervaded the tumour and the
VEGF production has stopped. This is accompanied by the
anastomosis of capillaries at the centre of the tissue. In this
case, the connection of the capillaries is enabled by the filopo-365
dia of the leading TECs which detect each other and change
their migration paths to coalesce. When interstitial flow is
considered, there is only one anastomosis at a similar time
(Fig. 3g) because convection delays the activation of TECs
from the left-hand side capillary.370
The fourth row of Fig. 3 shows the final results of these
simulations. At this point, the vascular networks are fully de-
veloped and they completely pervade the tumour and its sur-
roundings. Their shape is, however, remarkably different. We
show in Fig. 3q the superimposed skeletons of these networks375
which are obtained using two-fold-iteration parallel thinning
algorithm based on [59] plus a sequential thinning algorithm.
The neo-vessels that approximately match in both simula-
tions are those created by the first activated TECs, when the
VEGF distributions were most similar. After that moment,380
convection altered the distributions leading to different pat-
terns. As shown in Fig. 3p, the highest velocities are attained
in the two leading vessels that join the arterial and venous
sides of the capillary bed. The majority of the fluid that flows
through the new vascular network goes through these vessels,385
whose reduced calibres increase the velocity.
In Fig. 3r we show the velocity magnitude and phase-field
profiles along a cut-line marked with black colour in Fig. 3p.
The cut is perpendicular to one of the main capillaries that
connect the parent vessels and includes part of the extravas-390
cular region. The smoothness of the profiles shows that the
numerical methods are able to capture not only the phase-
field interface, but also the large gradients of the velocity field.
The velocity curve plateaus in the intra- and extravascular
regions, being almost ten-fold higher inside the capillaries. 395
These two plateaus are connected through smooth transi-
tions to a third one that is smaller and corresponds to the
transvascular region. The low hydraulic conductivity in the
transvascular region hinders the extravasation of the fluid.
We show this in Fig. 3s, where we draw fluid streamlines 400
that cross the black line at the centre of the figure. The
streamlines colour and thickness are plotted according to the
velocity of the fluid: The darker and thicker the streamline,
the higher the velocity. Note that all streamlines but one
remain within the intravascular region. The only one that 405
transverses the vascular wall is thin, indicating a small ve-
locity. Fig. 3s also shows that the model captures how the
streamlines separate from each other at the centre of the plot
as they go through a capillary intersection and the velocity
is reduced. This highlights the accuracy of the simulations. 410
Electronic supplementary material, figure S1 shows four
additional simulations in which we modified the arterio/venous
conditions of capillaries by modifying the boundary condi-
tions for the pressure field in the initial capillaries. There,
different configurations of the parent capillaries alter the vas- 415
cular patterns, although in every one the tumour and its
surroundings get pervaded by capillaries. The main differ-
ence is that the location of connections of the networks to
the vascular patterns tends to be at the venous side of the
capillary bed. 420
3 Results
The neovasculature grows more prominently against
the flow
Although our model predicts intra-, trans- and extravascular
flow in a tissue with a time-evolving vascular network, we 425
will initially use it to study a flow-controlled experiment in
which the fluid velocity is constant and known. The goal is
to provide a fluid-dynamics explanation of the experiments
reported in [18]. In these experiments, a microfluidic device
allows to create in vitro microvascular tissues with simulta- 430
neous control of the VEGF spatial concentration gradient
and the interstitial flow. Initially (left-hand side of Fig. 4),
there is a pre-existing vascular network in the central part
of the device. When the experiment starts, a constant con-
centration of VEGF is established on the lateral boundaries 435
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Figure 4. Flow-mediated angiogenesis with a controlled, uniform fluid velocity. In the top-row simulation, there is no flow. In the bottom-row
simulation the fluid velocity is 6 µm s−1. For both computations, time grows from left to right. The results show that our model predicts more
prominent growth of the neovasculature against the flow, as observed in the recent experiment [18]. The VEGF was kept constant on the lateral
boundaries with concentration f = fhyc . Boundary conditions in the vertical direction were assumed to be periodic. The computation was performed
on a tissue of size 1000 µm× 1000 µm. Since this computation is performed on a larger piece of tissue, we added random perturbations to the TEC
velocity field orientation [27] to produce a more realistic vascular pattern. We have verified (data not shown) that this does not have an impact on
the symmetry breaking mechanism. Similar computations without random perturbations also produce more prominent capillary growth against the
flow.
and a uniform flow in horizontal direction is applied. When a
controlled interstitial flow is applied, the experiments show a
strikingly non-symmetric distribution of the neovasculature,
while similar experiments without flow produce symmetric
growth; see [18] for more details. The detailed mechanisms440
that control the symmetry breaking are not well understood.
A potential explanation for this observation is that TECs
detect the flow and bias their migration direction; in fact, a
similar behaviour was recently observed for cancer cells [60].
Although this has not been observed for endothelial cells, it445
is a plausible mechanism because, by migrating against the
flow, TECs travel in the direction of a positive pressure gra-
dient. When the migrating TEC anastomoses with another
capillary, the newly created vessel will be effectively carry-
ing flow because it joins two points with different pressures.450
Another relevant hypothesis is that interstitial flow alters
the TEC activation process by accelerating the transition
from a quiescent to a migratory phenotype [61]. Our model,
however, indicates that no direct sensing is necessary to re-
produce preferential migration against the flow. The simplest455
hypothesis that flow only modifies angiogenesis by altering
the VEGF distribution allowed us to qualitatively reproduce
the experimental observation. Fig. 4 shows the computational
results for vanishing interstitial flow (top) and for a constant
flow rate with velocity 6 µm s−1. The results clearly show460
that the new vessels grow symmetrically with no flow (top)
and preferentially upstream with flow (bottom). The model
suggests that this happens due to a non-symmetric distri-
bution of VEGF. If the VEGF transport was purely diffu-
sive, the concentration distribution would be symmetric, but465
the combination of convective and diffusive transport, with
the consumption of VEGF by the initial capillary network
produces a non-symmetric VEGF distribution that leads to
preferential vascular growth against the flow.
Interstitial flow may facilitate the angiogenic switch470
of small tumours
Here, we study the effect of interstitial flow on the avascular
to vascular switch of a small tumour. We perform a para-
metric study in which we alter the size of the tumour that
is producing VEGF. We analyse whether interstitial flow 475
enhances the tumour’s ability to trigger angiogenesis. Our
results are shown in Fig. 5, where we present simulations for
tumours of radius RT = 56.75, 37.50, and 25.00µm, from left
to right. The top and middle rows of this figure correspond
to intermediate time steps of simulations with and without 480
VEGF convection, respectively. The bottom row corresponds
to the final vascular patterns for all cases. For these simu-
lations we have used the same setup, mesh, boundary and
initial conditions as the simulations in the previous example
(Fig. 3a). 485
We observe a significant impact of interstitial flow on the
results. For all the simulations with VEGF convection, the
vascular network develops only from the right-hand side cap-
illary, while in the absence of convection, when angiogenesis
occurs, new vessels grow from both parent capillaries. The 490
main conclusion from these simulations is that interstitial
flow may play a role in enhancing the malignancy of small
tumours. As shown in the simulations at the right-most col-
umn of the figure, small tumours, may not be able to trigger
angiogenesis in the absence of convection. On the contrary, 495
the model with convection predicts that the same tumour
gets fully vascularised and becomes malignant.
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Figure 5. Convection-increased angiogenesis. VEGF reaches the initial capillaries at different times when the tumour radius is varied (56.25,
37.50, and 25.00 µm). In the absence of convection the smaller tumour is not able to trigger angiogenesis. The green colour scale represents VEGF
concentration.
Intratumoral pressure may increase the tumour’s
ability to induce angiogenesis through stronger
interstitial flow500
So far we have assumed the fluid pressure inside the tumour
to be equal to that in the host tissue. This is, however, not nec-
essarily true. Cancer cells replicate rapidly and group forming
densely packed tumours. The growth generates mechanical
stress, which is transmitted to the fluid leading to a pressure505
rise. Furthermore, this high fluid pressure is not alleviated
due to the absence of functional lymphatic and blood vessels.
We use our computational method to study whether an intra-
tumoral pressure higher than that of its micro-environment
affects angiogenesis through VEGF convection.510
The proposed mathematical model does not explicitly con-
sider cancer cell density; instead, we assume that the tumour
is located in a fixed hypoxic circular region at the centre
of the tissue; see Fig. 6. This region is assigned an intratu-
moral pressure p = pt. From a computational point of view,515
we impose this constraint using the penalty method [62].
Fig. 6 and video V2 in the electronic supplementary material
show the result of a simulation in which pt = 7.4 mmHg and
fhyc = 90 ng ml−1. The computation starts with two initial
capillaries at the left and right edges of a 375µm× 375µm520
square tissue and one ∼ 60µm-radius hypoxic region at its
centre. The left capillary is considered to be on the arte-
rial side of the micro-circulatory system and have a constant
pressure p = 10 mmHg that we impose by way of a boundary
condition. The initial capillary on the right-hand side repre-525
sents the venous side and its associated pressure boundary
condition is p = 0 mmHg.
Fig. 6a displays the results before the TECs reach the
tumour. There, we plot contour lines of pressure (orange)
and VEGF (green), a black circle rendering the contour of 530
the tumour, glyphs representing the convective term uf , and
the distribution of VEGF and capillaries. The pressure con-
tour lines are mostly parallel to the initial capillaries as in
other simulations, showing the pressure drop between them.
The imposed intratumoral pressure, however, disrupts the 535
parallelism in the central region and reveals the location of
the tumour. In particular, the contour line p = 7 bends to-
wards the right surrounding the tumour and exposing its
location. The tumour produces all the VEGF in the domain
that reaches the capillaries through diffusion and convection. 540
Convection is, however, virtually non-existent inside the tu-
mour as shown by the absence of glyphs in the intratumoral
region. After being produced, the VEGF escapes the tumour
by diffusion only. Once in the extracellular matrix, intersti-
tial flow starts to play a role in the VEGF distribution. This 545
is specially noticeable on the right-hand side of the tumour,
as shown by the colour arrows representing the convection
term. There, the transition between the intratumoral pres-
sure and the extravascular pressure in a small region gener-
ates high pressure gradients. In turn, convection is increased 550
and drives VEGF away from the tumour creating a region
with low values of VEGF. As a result and contrary to pre-
vious simulations, video V2 in the electronic supplementary
material shows how capillaries originated from the venous
side turn at the tumour boundary, rather than going through 555
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Figure 6. Influence of intratumoral pressure. Intratumoral pressure alters the distribution of VEGF which, in turn, drives capillaries around the
tumour. The fluid velocity inside the tumour is low, even within the capillaries that transverse the tumour.
it. This trend continues as the simulation evolves. Fig. 6b
shows how one of these venous capillaries has stopped its
growth and anastomosed, while the other two have run along
the tumour boundary. Only when the VEGF has been con-
sumed in the vicinity of the tumour, they penetrate the lesion.560
Fig. 6b also displays streamlines of the extravascular fluid
velocity. Each streamline starts at the left-hand side capillary
and its thickness varies according to the norm of the fluid
velocity. Interestingly, few streamlines transverse the tumour
and those that do it are very thin, indicating small velocities.565
The highest fluid velocity in the extravascular region occurs
between capillaries that are very close to each other but have
not anastomosed yet. The vascular network continues evolv-
ing until all the VEGF in the domain has been consumed. We
present a snapshot of this last step in Fig. 6c, where we show570
the final vascular network represented by its skeleton (red
lines), streamlines of the velocity field (black lines), and the
continuous velocity field (shades of purple). As in previous
simulations with a similar setup, the final vascular network
is non-symmetric, being denser towards the venous side due575
to the effect of convection. The difference here is that the
intratumoral pressure has prevented capillaries from enter-
ing the tumour. The velocity field highlights, first, that the
fluid flows more rapidly within the capillaries and, second,
that the velocity inside the tumour is very low. In fact, the580
capillaries that transverse the tumour present velocities close
to zero. The intratumoral pressure has rendered these capil-
laries non-functional. Finally, as in Fig. 6b, the streamlines
barely penetrate the tumour.
Importantly, the simulation predicts that even though585
the tumour is vascularised, nutrients, oxygen, or systemically
administered drugs cannot easily reach the tumour’s inte-
rior, resulting in an increased tumour malignancy [63]. The
fluid flow both within the capillaries and in the extravascular
region does not favour their penetration into the tumour.590
4 Discussion
The role of interstitial flow in tumour angiogenesis is not well
understood. In principle, interstitial flow could affect angio-
genesis in multiple ways, such as for example, modifying the
VEGF concentration distribution via convective transport,595
altering the TEC activation process, or biasing the migration
direction of tip cells. Here, we used a computational model
to show that accounting for the VEGF convective transport
mechanisms with a physiological flow rate produces signifi-
cant changes in the angiogenesis process, with a striking bias600
of vascular growth upstream the flow. Our results provide a
fluid-dynamics explanation for the experiments reported in
[18], which show non-symmetric neovasculature with more
prominent growth against the flow. Although the simplest
hypothesis that flow only modifies angiogenesis by altering 605
the VEGF distribution allowed us to qualitatively reproduce
a non-trivial experimental observation, it is unlikely that cells
are unable to interpret signals directly. In fact, as an indi-
cation of the ability of cells to sense flow directly, it was
observed that TECs travelling against the flow have more 610
filopodia that those moving with the flow [64]. However, our
model suggests that active sensing may not be the dominant
mechanism.
The model also predicts that tumour angiogenic factor
convection may play a role in enhancing the malignancy of 615
small tumours. Including the high intratumoral fluid pres-
sure in the model shows an increased ability of the tumour
to trigger angiogenesis. In addition, the delayed capillary
penetration and the low fluid velocity within the tumour sug-
gest a potential increase in tumour malignancy, as oxygen, 620
nutrients or even drugs may not reach tumour cells.
The model can be extended and improved in multiple
ways. The major limitation of our model at this point is
that the intravascular flow compartment does not capture
the complex haemodynamic interactions occurring across a 625
microcirculatory network. This includes the shear-thinning
behaviour of blood and the heterogeneous flow resistance pro-
duced by a non-uniform distribution of erythrocytes. How-
ever, an accurate computation of the intravascular flow on
a time-evolving vascular network is an open scientific prob- 630
lem that is out of the scope of this paper. Therefore, since
our main interest is interstitial flow rather than intravascular
flow, we employed a simplified intravascular flow model that
produces realistic extravascular flows. The model may also
be enhanced by the inclusion of convection-diffusion equa- 635
tions for nutrients, oxygen, or systemically-delivered drugs.
Also, the initial geometry of capillaries and tumours has been
simplified. The predictive capabilities of the model could be
augmented using geometries from in vivo three-dimensional
imaging. Its extension to three dimensions does not require 640
any modification of the model neither of the numerical meth-
ods. Another possible refinement of the model is to consider
the fact that several tumour angiogenic factors are known to
increase the patency of capillaries [4]. This mechanism may
be built into the model by transforming the parameter κt 645
into a function that depends on the concentration of that
particular tumour angiogenic factor. Finally, a proposed line
9
of further research is to change the definition of the hydraulic
conductivity to capture the intratumoral pressure.
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